NCT06794775
- Conditions
- Malignant Melanoma Stage III, Melanoma, Neoplasms, +10 more
- Locations
-
- Sahlgrenska University Hospital Gothenburg, Sweden
- Skane University Hospital Lund, Sweden
- Karolinska University Hospital Stockholm, Sweden
Clinical trial condition
Malignant Melanoma Stage III
Explore clinical trials studying Malignant Melanoma Stage III. Study availability and eligibility vary by location and protocol.
7 public trials
1 recruiting study
Malignant Melanoma Stage III trial results
NCT03493230
- Conditions
- Malignant Melanoma Stage III, Malignant Melanoma Stage IV, Melanoma, +11 more
- Locations
-
- nice University hospital Nice, France
- Conditions
- Malignant Melanoma Stage III, Melanoma, Neoplasms, +10 more
- Locations
-
- Melanoma Institute Australia Sydney, Wollstonecraft NSW, Australia
- Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands
NCT01302496
- Conditions
- Malignant Melanoma Stage III, Malignant Melanoma Stage IV, Melanoma, +11 more
- Locations
-
- UZ Brussel Jette, Brabant, Belgium
NCT01676779
- Conditions
- Malignant Melanoma Stage III, Malignant Melanoma Stage IV, Melanoma, +11 more
- Locations
-
- UZ Brussel Brussels, Belgium
Completed
IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma
NCT01189383
- Conditions
- Malignant Melanoma Stage III, Malignant Melanoma Stage IV, Melanoma, +11 more
- Locations
-
- Baylor University Medical Center Dallas, Texas, United States
Active, Not Recruiting
Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma
NCT04949113
- Conditions
- Malignant Melanoma Stage III, Melanoma, Neoplasms, +10 more
- Locations
-
- The Angeles Clinic Los Angeles, California, United States
- MD Anderson Cancer Center Houston, Texas, United States
- Melanoma Institute Australia (MIA) Sydney, New South Wales, Australia
- Princess Alexandra Hospital Brisbane, Australia